Orchids Paper Products Company (NYSEMKT:TIS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Wednesday, May 10th.
According to Zacks, “Orchids Paper Products Company is a tissue paper company that manufacturers and converts tissue product for the private label consumer market. “
TIS has been the subject of a number of other reports. Jefferies Group LLC raised their target price on Orchids Paper Products Company from $25.00 to $26.00 and gave the company a “hold” rating in a research note on Wednesday, March 8th. TheStreet lowered Orchids Paper Products Company from a “b-” rating to a “c” rating in a research note on Monday, May 1st.
Orchids Paper Products Company (NYSEMKT:TIS) last issued its quarterly earnings data on Monday, May 1st. The basic materials company reported ($0.08) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.11 by $0.19. The business had revenue of $35.40 million during the quarter, compared to the consensus estimate of $40.08 million. The business’s revenue for the quarter was down 25.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.56 earnings per share.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.chaffeybreeze.com/2017/05/20/zacks-investment-research-lowers-orchids-paper-products-company-tis-to-sell-updated.html.
In other news, CFO Rodney D. Gloss acquired 2,100 shares of the stock in a transaction that occurred on Friday, May 19th. The stock was purchased at an average cost of $12.99 per share, for a total transaction of $27,279.00. Following the completion of the transaction, the chief financial officer now directly owns 9,600 shares in the company, valued at $124,704. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Mario Armando Garcia sold 65,000 shares of Orchids Paper Products Company stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $15.23, for a total value of $989,950.00. The disclosure for this sale can be found here. Over the last quarter, insiders purchased 31,498 shares of company stock valued at $432,637 and sold 140,000 shares valued at $2,078,200.
Large investors have recently added to or reduced their stakes in the stock. Guggenheim Capital LLC boosted its stake in Orchids Paper Products Company by 27.6% in the fourth quarter. Guggenheim Capital LLC now owns 42,760 shares of the basic materials company’s stock valued at $1,120,000 after buying an additional 9,239 shares during the last quarter. State Street Corp boosted its stake in Orchids Paper Products Company by 28.4% in the fourth quarter. State Street Corp now owns 158,839 shares of the basic materials company’s stock valued at $4,159,000 after buying an additional 35,161 shares during the last quarter. Two Sigma Investments LP purchased a new stake in Orchids Paper Products Company during the fourth quarter valued at approximately $240,000. Dimensional Fund Advisors LP boosted its stake in Orchids Paper Products Company by 4.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 399,325 shares of the basic materials company’s stock valued at $10,454,000 after buying an additional 18,310 shares during the last quarter. Finally, Cubic Asset Management LLC boosted its stake in shares of Orchids Paper Products Company by 0.8% in the first quarter. Cubic Asset Management LLC now owns 48,430 shares of the basic materials company’s stock worth $1,162,000 after buying an additional 375 shares in the last quarter.
Orchids Paper Products Company Company Profile
Orchids Paper Products Company is a supplier of consumer tissue products. The Company produces bulk tissue paper, known as parent rolls, and converts parent rolls into finished products, including paper towels, bathroom tissue and paper napkins. The Company offers customers a range of private label products across the value, premium and ultra-premium market segments.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Orchids Paper Products Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orchids Paper Products Company and related companies with MarketBeat.com's FREE daily email newsletter.